Conditions: Acute Coronary Syndrome (ACS)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1741
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Apixaban intervention 2: Apixaban intervention 3: Placebo intervention 4: Apixaban
Intervention descriptions: intervention 1: Tablets, Oral, 2.5 mg, twice daily, 26 weeks intervention 2: Tablets, Oral, 10 mg, once daily, 26 weeks intervention 3: Tablets, Oral, 0, twice daily, 26 weeks intervention 4: Tablets, Oral 10 mg, twice daily, 26 weeks

Protocol document: